AlphaYou
Overview
Smart money at a glance
Filings to Oct 5, 2026No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- $0No open-market trades
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, latest quarter
- NoneNo large changes
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Market overview
Fundamentals Oct 5- Open
- $1.73
- 52-wk high
- $3.80
- High
- $1.74
- 52-wk low
- $1.30
- Low
- $1.68
- Prev close
- $1.73
- Mkt cap
- $124.1M
- Volume
- 503.4K
- Fwd P/E
- 58.8x
- Beta
- 1.47
- P/S
- 0.5x
- P/B
- 141.5x
- Profit margin
- -26.1%
- Op margin
- +9.2%
- ROE
- +0.0%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about AMTX filings
Are insiders buying or selling Aemetis Inc (AMTX) stock?
Neither. Aemetis Inc (AMTX) insiders filed no open-market purchases or sales in the 90 days to Oct 5, 2026, according to SEC Form 4 filings.
Which members of Congress have traded AMTX recently?
None. No member of Congress disclosed a AMTX trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this AMTX smart-money data?
This summary uses filings available on Oct 5, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What insiders are doing
Sells (1)
- ST
Simon Timothy Alan
$21K
sold
How top traders are positioned
No tracked top-trader positions in AMTX right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in 55.2% above what analysts expected.
Last report
Aug 6, 2026
Period ending
Jun 30, 2026
Earnings per share
-$0.29 expected
Revenue
No reported revenue on record
Previous reports
All values in USD| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 6, 2026 | -$0.13 / -$0.29Alpha Vantage | +55.17% beat | Unavailable | Unavailable |
| Mar 31, 2026 | May 7, 2026 | -$0.30 / -$0.20Alpha Vantage | -50.00% miss | Unavailable | Unavailable |
| Dec 31, 2025 | Mar 12, 2026 | -$0.09 / -$0.19Alpha Vantage | +54.97% beat | Unavailable | Unavailable |
| Sep 30, 2025 | Nov 6, 2025 | -$0.37 / -$0.21Alpha Vantage | -76.19% miss | Unavailable | Unavailable |
| Jun 30, 2025 | Aug 7, 2025 | -$0.41 / -$0.35Alpha Vantage | -17.14% miss | Unavailable | Unavailable |
| Mar 31, 2025 | May 8, 2025 | Unavailable | - | Unavailable | Unavailable |
| Dec 31, 2024 | Mar 13, 2025 | -$0.35 / -$0.41Alpha Vantage | +12.54% beat | Unavailable | Unavailable |
| Sep 30, 2024 | Nov 12, 2024 | -$0.38 / -$0.42Alpha Vantage | +9.52% beat | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
Reports Nov 5, 2026, in 31 days
Financials
Is the business strong?
This company is not yet profitable.
- Net margin
- -26.1%
- Forward P/E
- 58.82
- Market cap
- $124M
Valuation
- P/S0.54
- P/B141.51
Quality
- Operating margin9.2%
- ROE0.0%
- ROA-2.7%
Growth
- Beta1.47
Technicals
Price structure
This stock is under pressure.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace